Physician profile
Samardeep Gupta
NPI 1891712253
$58,128.25
in general payments reported to CMS, 2019-2025
11 companies · $6,801 in 2025
The $6,801 reported for 2025 was more than what 88% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,046 · 2020: $15K · 2021: $3,250 · 2022: $14K · 2023: $3,736 · 2024: $8,342 · 2025: $6,801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $1,432 · Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,640.00 |
| Travel and Lodging | $1,432.20 |
| Food and Beverage | $806.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $20,909.66 | 2019-2025 | Tremfya |
| Ucb, INC. | $11,508.50 | 2020-2024 | Bimzelx |
| Lilly USA, LLC | $8,550.00 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $8,250.00 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $4,396.34 | 2025 | |
| Glaxosmithkline, LLC. | $2,275.00 | 2022 | |
| Janssen Global Services, LLC | $1,500.00 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $500.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $108.75 | 2019 | |
| Cardinal Health 110 LLC | $100.00 | 2022 | |
| Amgen INC. | $30.00 | 2023 | Tavneos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samardeep Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.